NANNI, PATRIZIA
NANNI, PATRIZIA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
2011: the immune hallmarks of cancer
2011 F. Cavallo; C. De Giovanni; P. Nanni; G. Forni; P. Lollini
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
2018 Leoni, Valerio; Vannini, Andrea; Gatta, Valentina; Rambaldi, Julie; Sanapo, Mara; Barboni, Catia; Zaghini, Anna; Nanni, Patrizia; Lollini, Pier-Luigi; Casiraghi, Costanza; Campadelli-Fiume, Gabriella
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome
2009 C. De Giovanni; G. Nicoletti; A. Palladini; S. Croci; L. Landuzzi; A. Antognoli; A. Murgo; A. Astolfi; S. Ferrini; M. Fabbi; A.M. Orengo; A. Amici; M. L. Penichet; L. Aurisicchio; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini.
A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
2011 Gasparre G; Kurelac I; Capristo M; Iommarini L; Ghelli A; Ceccarelli C; Nicoletti G; Nanni P; De Giovanni C; Scotlandi K; Betts CM; Carelli V; Lollini PL; Romeo G; Rugolo M; Porcelli AM
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
2018 Manara, Maria Cristina; Valente, Sergio; Cristalli, Camilla; Nicoletti, Giordano; Landuzzi, Lorena; Zwergel, Clemens; Mazzone, Roberta; Stazi, Giulia; Arimondo, Paola B; Pasello, Michela; Guerzoni, Clara; Picci, Piero; Nanni, Patrizia; Lollini, Pier-Luigi; Mai, Antonello; Scotlandi, Katia
Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab.
2014 Castagnoli, L; Iezzi, M; Ghedini, Gc; Ciravolo, V; Marzano, G; Lamolinara, A; Zappasodi, R; Gasparini, P; Campiglio, M; Amici, A; Chiodoni, C; Palladini, Arianna; Lollini, PIER LUIGI; Triulzi, T; Menard, S; Nanni, Patrizia; Tagliabue, E; Pupa, Sm
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC
2022 Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna
Antimetastatic activity of a preventive cancer vaccine.
2007 P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S. Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini.
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.
2004 DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P. L.
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
2019 De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Lollini, Pier-Luigi; Nanni, Patrizia
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
2019 Nanni, Patrizia; Landuzzi, Lorena; Manara, Maria Cristina; Righi, Alberto; Nicoletti, Giordano; Cristalli, Camilla; Pasello, Michela; Parra, Alessandro; Carrabotta, Marianna; Ferracin, Manuela; Palladini, Arianna; Ianzano, Marianna L; Giusti, Veronica; Ruzzi, Francesca; Magnani, Mauro; Donati, Davide Maria; Picci, Piero; Lollini, Pier-Luigi; Scotlandi, Katia
Cancer biology, what we know and what we don't know.
2006 P. Nanni; C. De Giovanni; P.-L. Lollini
Cancer immunoprevention
2005 P.L. Lollini; C. De Giovanni; T. Pannellini; F. Cavallo; G. Forni; P. Nanni
Cancer immunoprevention: from mice to early clinical trials
2018 Palladini, Arianna; Landuzzi, Lorena; Lollini, Pier-Luigi; Nanni, Patrizia
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
2019 De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Nicoletti, Giordano; Ruzzi, Francesca; Amici, Augusto; Croci, Stefania; Nanni, Patrizia; Lollini, Pier-Luigi
CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine.
2006 A. Comes; O. Rosso; A.M. Orengo; E. Di Carlo; C. Sorrentino; R. Meazza; T. Piazza; B. Valzasina; P. Nanni; M.P. Colombo; S. Ferrini
CD99 Acts as an Oncosuppressor in Osteosarcoma.
2006 Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.; Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K.
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity
2007 Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
2014 Riccardo, F; Arigoni, M; Buson, G; Zago, E; Iezzi, M; Longo, D; Carrara, M; Fiore, A; Nuzzo, S; Bicciato, S; Nanni, Patrizia; Landuzzi, Lorena; Cavallo, F; Calogero, R; Quaglino, E.
Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment
2014 L. Iommarini;I. Kurelac;M. Capristo;M. A. Calvaruso;V. Giorgio;C. Bergamini;A. Ghelli;P. Nanni;C. De Giovanni;V. Carelli;R. Fato;P. L. Lollini;M. Rugolo;G. Gasparre;A. M. Porcelli
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 2011: the immune hallmarks of cancer | F. Cavallo; C. De Giovanni; P. Nanni; G. Forni; P. Lollini | 2011-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors | Leoni, Valerio; Vannini, Andrea; Gatta, Valentina; Rambaldi, Julie; Sanapo, Mara; Barboni, Catia;... Zaghini, Anna; Nanni, Patrizia; Lollini, Pier-Luigi; Casiraghi, Costanza; Campadelli-Fiume, Gabriella | 2018-01-01 | PLOS PATHOGENS | - | 1.01 Articolo in rivista | HSV IL-12 PLoS Pathog 2018.pdf |
| A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome | C. De Giovanni; G. Nicoletti; A. Palladini; S. Croci; L. Landuzzi; A. Antognoli; A. Murgo; A. Ast...olfi; S. Ferrini; M. Fabbi; A.M. Orengo; A. Amici; M. L. Penichet; L. Aurisicchio; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini. | 2009-01-01 | HUMAN GENE THERAPY | - | 1.01 Articolo in rivista | - |
| A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function | Gasparre G; Kurelac I; Capristo M; Iommarini L; Ghelli A; Ceccarelli C; Nicoletti G; Nanni P; De ...Giovanni C; Scotlandi K; Betts CM; Carelli V; Lollini PL; Romeo G; Rugolo M; Porcelli AM | 2011-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy | Manara, Maria Cristina; Valente, Sergio; Cristalli, Camilla; Nicoletti, Giordano; Landuzzi, Loren...a; Zwergel, Clemens; Mazzone, Roberta; Stazi, Giulia; Arimondo, Paola B; Pasello, Michela; Guerzoni, Clara; Picci, Piero; Nanni, Patrizia; Lollini, Pier-Luigi; Mai, Antonello; Scotlandi, Katia | 2018-01-01 | MOLECULAR CANCER THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab. | Castagnoli, L; Iezzi, M; Ghedini, Gc; Ciravolo, V; Marzano, G; Lamolinara, A; Zappasodi, R; Gaspa...rini, P; Campiglio, M; Amici, A; Chiodoni, C; Palladini, Arianna; Lollini, PIER LUIGI; Triulzi, T; Menard, S; Nanni, Patrizia; Tagliabue, E; Pupa, Sm | 2014-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC | Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; S...calambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna | 2022-01-01 | TRANSLATIONAL LUNG CANCER RESEARCH | - | 1.01 Articolo in rivista | ADK-VR2 TLCR.pdf; tlcr-11-11-2216-coif.zip |
| Antimetastatic activity of a preventive cancer vaccine. | P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S.... Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini. | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. | DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P.... L. | 2004-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model | De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Lollini, Pier-Luig...i; Nanni, Patrizia | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | TSA cancers w suppl.pdf; cancers-11-01889-s001.zip |
| Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations | Nanni, Patrizia; Landuzzi, Lorena; Manara, Maria Cristina; Righi, Alberto; Nicoletti, Giordano; C...ristalli, Camilla; Pasello, Michela; Parra, Alessandro; Carrabotta, Marianna; Ferracin, Manuela; Palladini, Arianna; Ianzano, Marianna L; Giusti, Veronica; Ruzzi, Francesca; Magnani, Mauro; Donati, Davide Maria; Picci, Piero; Lollini, Pier-Luigi; Scotlandi, Katia | 2019-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | PDX bone Sci Rep.pdf |
| Cancer biology, what we know and what we don't know. | P. Nanni; C. De Giovanni; P.-L. Lollini | 2006-01-01 | - | Bononia University Press | 2.01 Capitolo / saggio in libro | - |
| Cancer immunoprevention | P.L. Lollini; C. De Giovanni; T. Pannellini; F. Cavallo; G. Forni; P. Nanni | 2005-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Cancer immunoprevention: from mice to early clinical trials | Palladini, Arianna; Landuzzi, Lorena; Lollini, Pier-Luigi; Nanni, Patrizia | 2018-01-01 | BMC IMMUNOLOGY | - | 1.01 Articolo in rivista | Immunoprevention BMC Immunology.pdf |
| Cancer Vaccines Co-Targeting HER2/Neu and IGF1R | De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Nicoletti, Gio...rdano; Ruzzi, Francesca; Amici, Augusto; Croci, Stefania; Nanni, Patrizia; Lollini, Pier-Luigi | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | IGF1R vax Cancers-11-00517 (1).pdf; cancers-11-00517-s001.pdf |
| CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine. | A. Comes; O. Rosso; A.M. Orengo; E. Di Carlo; C. Sorrentino; R. Meazza; T. Piazza; B. Valzasina; ...P. Nanni; M.P. Colombo; S. Ferrini | 2006-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| CD99 Acts as an Oncosuppressor in Osteosarcoma. | Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.;... Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K. | 2006-01-01 | MOLECULAR BIOLOGY OF THE CELL | - | 1.01 Articolo in rivista | - |
| CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity | Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni ...P; Lollini PL; Bernard A; Picci P | 2007-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. | Riccardo, F; Arigoni, M; Buson, G; Zago, E; Iezzi, M; Longo, D; Carrara, M; Fiore, A; Nuzzo, S; B...icciato, S; Nanni, Patrizia; Landuzzi, Lorena; Cavallo, F; Calogero, R; Quaglino, E. | 2014-01-01 | BMC GENOMICS | - | 1.01 Articolo in rivista | BMC Genomics Nanni.pdf |
| Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment | L. Iommarini;I. Kurelac;M. Capristo;M. A. Calvaruso;V. Giorgio;C. Bergamini;A. Ghelli;P. Nanni;C.... De Giovanni;V. Carelli;R. Fato;P. L. Lollini;M. Rugolo;G. Gasparre;A. M. Porcelli | 2014-01-01 | HUMAN MOLECULAR GENETICS | - | 1.01 Articolo in rivista | - |